- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Study offers new insights into why ex-smokers remain at elevated risk of lung disease

A new study by a team of McGill researchers could help explain why people who have quit smoking remain at elevated risk of lung disease long after their last cigarette.
Their paper, published in Translational Research, provides one of the most detailed pictures to date of how quitting smoking affects the human lung at the cellular level.
"Current smokers have the highest risk of deadly diseases such as lung cancer, but former smokers still face a higher risk than people who never smoked. Despite more than a century of research on smoking, we don't fully understand why," said senior author Carolyn Baglole, Professor in McGill's Department of Pharmacology and Therapeutics and researcher at the Research Institute of the McGill University Health Centre.
"Our findings show that while some damage appears reversible, other changes persist long after people stop smoking,” she said.
Mapping recovery after smoking
Using publicly available data, the researchers analyzed more than 100,000 lung cells from 21 people: nine who had never smoked, five current smokers and seven former smokers. The data captured molecular activity across more than 40 lung cell types, offering a highly detailed picture of how the lungs respond to smoking and of recovery after quitting.
Some lung cells recovered after smoking ended, while others showed lasting changes in genes linked to tissue structure, immune function and blood vessel health. In some cases, former smokers displayed molecular patterns not seen in either current smokers or people who had never smoked, suggesting quitting leaves its own biological signature on the lung.
Could inform treatment
"These findings are an important step toward understanding what damage caused by smoking can heal and what may be permanent," said first author Nicole Heimbach, a doctoral student at McGill. "By knowing what damage remains after quitting, we can better understand how smoking-related diseases develop and how to treat them."
Although smoking rates have declined over the past several decades, about one in eight Canadian adults still uses tobacco, which remains one of the leading causes of preventable death.
Reference: Nicole S. Heimbacha, Jun Dinga, David H. Eidelmana, Carolyn J. Baglole; Single cell RNA-sequencing meta-analysis identifies the molecular signature of smoking cessation on the human lung; Journal: Translational Research; DOI 10.1016/j.trsl.2026.06.012
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

